• OPEN AN ACCOUNT
Indian Indices
Nifty
25,585.30 261.75
(1.03%)
Sensex
83,467.66 862.23
( 1.04%)
Bank Nifty
57,422.55 622.65
( 1.10%)
Nifty IT
35,531.05 129.25
( 0.37%)
Global Indices
Nasdaq
46,277.70 -13.77
(-0.03%)
Dow Jones
6,693.00 27.69
(0.42%)
Hang Seng
48,217.22 544.55
(1.14%)
Nikkei 225
9,424.75 -28.02
(-0.30%)
Forex
USD-INR
88.76 0.08
(0.09%)
EUR-INR
102.80 0.03
(0.03%)
GBP-INR
118.12 -0.16
(-0.14%)
JPY-INR
0.58 0.00
(0.21%)

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
535341
INE04LG01015
80.43711
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PAR
8.89
125.8
EPS(TTM)
Face Value()
Div & Yield %
11.5
10
0
 

Shanti Overseas (India) Ltd - Integrated Filing- Financial
Aug 08,2025
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, August 08, 2025 have interalia, considered and approved Un-audited Standalone and Consolidated Financial Results together with Limited Review Report thereon for the Quarter ended 30th June, 2025